BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11215814)

  • 1. Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha.
    Geng Y; Choubey D
    J Biol Regul Homeost Agents; 2000; 14(4):263-8. PubMed ID: 11215814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of E2F-4/DP-1-stimulated transcription by p202.
    Choubey D; Gutterman JU
    Oncogene; 1997 Jul; 15(3):291-301. PubMed ID: 9233764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of E2F-mediated transcription by p202.
    Choubey D; Li SJ; Datta B; Gutterman JU; Lengyel P
    EMBO J; 1996 Oct; 15(20):5668-78. PubMed ID: 8896460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1).
    Gutterman JU; Choubey D
    Cell Growth Differ; 1999 Feb; 10(2):93-100. PubMed ID: 10074903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor proteins as regulators of cell differentiation.
    Li ZR; Hromchak R; Mudipalli A; Bloch A
    Cancer Res; 1998 Oct; 58(19):4282-7. PubMed ID: 9766653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.
    Xin H; Curry J; Johnstone RW; Nickoloff BJ; Choubey D
    Oncogene; 2003 Jul; 22(31):4831-40. PubMed ID: 12894224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    Alevizopoulos K; Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
    Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
    J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
    Vrana JA; Saunders AM; Chellappan SP; Grant S
    Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
    Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate.
    Jiang H; Lin J; Young SM; Goldstein NI; Waxman S; Davila V; Chellappan SP; Fisher PB
    Oncogene; 1995 Sep; 11(6):1179-89. PubMed ID: 7566979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.
    Melamed D; Tiefenbrun N; Yarden A; Kimchi A
    Mol Cell Biol; 1993 Sep; 13(9):5255-65. PubMed ID: 7689148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.
    Alexander K; Hinds PW
    Mol Cell Biol; 2001 Jun; 21(11):3616-31. PubMed ID: 11340156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
    Sidle A; Palaty C; Dirks P; Wiggan O; Kiess M; Gill RM; Wong AK; Hamel PA
    Crit Rev Biochem Mol Biol; 1996 Jun; 31(3):237-71. PubMed ID: 8817077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.